Tech Company Financing Transactions

Orbis Medicines Funding Round

Forbion Capital Partners, Novo Holdings and private investors participated in a $28.3 million Seed funding round for Orbis Medicines. The round was announced by the company on 2/29/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Copenhagen, Undisclosed
Denmark

Phone

Undisclosed

Website

www.orbismedicines.com

Email Address

[email protected]

Overview

Our mission is to define a new era for macrocycle drugs and make great contributions to medicine. We are bringing together a world-class team to make this possible. Our broad pipeline is initially focused on delivering oral macrocycle candidates against targets validated by blockbuster biologic drugs.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Morten Dossing

        

Chief Technical Officer

Sevan Habeshian

        

Vice President

Daniela Brodbeck

        

Vice President

Daniel Greve

        

VP - Bus. Development

Simon Feldbaek

        

Browse more venture capital transactions:

Prev: 2/29/2024: Gradial venture capital transaction
Next: 2/29/2024: Bfree venture capital transaction

Share this article

Where The Data Comes From

We do our best to document tech company VC transactions. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary